Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael LeBlanc

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Genetic Epidemiology|January 27, 2009
Adaptively weighted association statisticsMichael LeBlanc, Charles Kooperberg
Genetic Epidemiology|January 18, 2008
Increasing the power of identifying gene x gene interactions in genome-wide association studiesCharles Kooperberg, Michael Leblanc
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2010
Boosting predictions of treatment successMichael LeBlanc, Charles Kooperberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Choosing phase II endpoints and designs: evaluating the possibilitiesMichael LeBlanc, Catherine Tangen
JAMA Oncology|November 26, 2015
Surrogates for Survival or Other End Points in OncologyMichael LeBlanc, Catherine Tangen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?David J Adelstein, Michael Leblanc
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 4, 2020
Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous endpointsJames Y Dai, Michael LeBlanc
Clinical Trials (London, England)|February 20, 2008
Interim futility analysis with intermediate endpointsBryan Goldman, Michael LeBlanc, John Crowley
Statistics in Biosciences|January 3, 2018
Structured detection of interactions with the directed lassoHristina Pashova, Michael LeBlanc, Charles Kooperberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Multiple Histology Phase II TrialsMichael Leblanc, Cathryn Rankin, John Crowley
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Genetic Epidemiology|January 27, 2009
Adaptively weighted association statisticsMichael LeBlanc, Charles Kooperberg
Genetic Epidemiology|January 18, 2008
Increasing the power of identifying gene x gene interactions in genome-wide association studiesCharles Kooperberg, Michael Leblanc
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2010
Boosting predictions of treatment successMichael LeBlanc, Charles Kooperberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Choosing phase II endpoints and designs: evaluating the possibilitiesMichael LeBlanc, Catherine Tangen
JAMA Oncology|November 26, 2015
Surrogates for Survival or Other End Points in OncologyMichael LeBlanc, Catherine Tangen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?David J Adelstein, Michael Leblanc
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 4, 2020
Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous endpointsJames Y Dai, Michael LeBlanc
Clinical Trials (London, England)|February 20, 2008
Interim futility analysis with intermediate endpointsBryan Goldman, Michael LeBlanc, John Crowley
Statistics in Biosciences|January 3, 2018
Structured detection of interactions with the directed lassoHristina Pashova, Michael LeBlanc, Charles Kooperberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Multiple Histology Phase II TrialsMichael Leblanc, Cathryn Rankin, John Crowley
Pageof 16